Tom Price was Senate-confirmed as secretary of health and human services on a party-line 52–47 vote on February 10, 2017. He will have responsibility over the National Institutes of Health and the Centers for Disease Control, among a number of other research and public health agencies.
This bill authorizes FY2017 appropriations and sets forth policies regarding the military activities of the Department of Defense (DOD), military construction, and the national security programs of the Department of Energy (DOE).
President Donald Trump has decided to retain Dr. Francis Collins as director of the US National Institutes of Health (NIH) until a permanent Director is appointed. The hold-over of Collins will provide some consistency to the agency during the uncertain budget period looming in 2017.
The Committee on Advancing Understanding of the Human Microbiome will hold its third meeting on January 30, 2017 in Washington, DC. This committee is charged with developing a research strategy to better understand the interactions between environmental chemicals and the human microbiomes and the implications of those interactions on human health risk.
Public Meeting: Synthetic Biology. To assist the U.S. Department of Defense’s Chemical and Biological Defense Program (CBDP), The National Academies of Sciences, Engineering, and Medicine has appointed an ad hoc committee to address the changing nature of the biodefense threat in the age of synthetic biology.
Federal science agencies in general will be barred from starting new programs or stopping old ones and from implementing funding increases submitted in the president’s fiscal year 2017 budget request.
Both the House and Senate have passed the fiscal year 2017 “National Defense Authorization Act." The NDAA is a bill, passed annually, that authorizes and sets policy for defense programs at the Defense and Energy Departments, including defense R&D.